UPDATED Aug 23, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PANG | €1.72 | 0% | -3.9% | €59.1m | n/a | PS4.1x | E58.2% | n/a | ||
XOMA | US$34.20 | 9.0% | 21.1% | US$413.4m | US$64.67 | PS9.2x | E58.2% | n/a | ||
A141080 | ₩141,200.00 | -9.7% | 50.7% | ₩5.1t | ₩168,333.33 | PE205.9x | E58.1% | n/a | ||
TH | CA$4.49 | 0.2% | 152.2% | CA$206.5m | CA$7.25 | PS1.8x | E58.1% | n/a | ||
CELC | US$52.42 | 1.2% | 202.1% | US$2.2b | US$69.43 | PB50.1x | E58.0% | n/a | ||
300463 | CN¥12.82 | 1.7% | 12.3% | CN¥7.8b | CN¥14.90 | PS3.3x | E58.0% | 0.8% | ||
600867 | CN¥8.46 | 0.2% | 9.7% | CN¥16.4b | CN¥9.53 | PS7.9x | E57.7% | 3.0% | ||
ALERS | €25.55 | 0.4% | 3.4% | €256.4m | €30.00 | PE64.1x | E57.6% | n/a | ||
LGVN | US$0.80 | 5.2% | -68.9% | US$12.1m | US$6.86 | PS5.9x | E57.6% | n/a | ||
BNGO | US$4.00 | 31.6% | -87.3% | US$18.7m | US$9.50 | PB0.4x | E57.5% | n/a | ||
XBRANE | SEK 0.29 | -0.3% | 66.5% | SEK 438.2m | n/a | PS1.6x | E57.5% | n/a | ||
CTX | zł41.00 | -1.0% | -49.4% | zł226.7m | zł99.47 | PS16.3x | E57.3% | n/a | ||
6996 | HK$6.41 | -3.5% | 1,065.5% | HK$4.4b | HK$2.99 | PS47.3x | E57.3% | n/a | ||
FTRE | US$8.34 | 3.7% | -62.2% | US$756.8m | US$7.44 | PB1.3x | E57.3% | n/a | ||
FENC | US$8.66 | 3.6% | 51.9% | US$241.0m | US$14.00 | PS7.2x | E57.2% | n/a | ||
CING | US$4.19 | 3.7% | -56.8% | US$22.7m | US$27.71 | PB4.1x | E57.2% | n/a | ||
GUD | CA$6.45 | 3.7% | 13.8% | CA$642.8m | CA$7.80 | PE1678.2x | E57.1% | n/a | ||
QNRX | US$7.20 | -3.7% | -66.0% | US$4.2m | US$40.67 | PB1.7x | E57.1% | n/a | ||
IVVD | US$0.52 | -26.4% | -48.5% | US$101.4m | US$4.00 | PS2.2x | E57.0% | n/a | ||
LGND | US$159.08 | 5.3% | 53.2% | US$3.1b | US$167.25 | PS16.6x | E57.0% | n/a | ||
GRCE | US$3.25 | -0.3% | 32.7% | US$44.9m | US$11.83 | PB0.7x | E57.0% | n/a | ||
SGMO | US$0.59 | 1.1% | -31.6% | US$176.9m | US$4.10 | PS2.2x | E56.8% | n/a | ||
LCTX | US$1.20 | 0% | 26.6% | US$274.0m | US$4.17 | PS25.1x | E56.8% | n/a | ||
ESLA | US$0.97 | 6.6% | -26.8% | US$35.9m | US$16.00 | PE-3x | E56.7% | n/a |